We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
-7.19%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.49B
AUM Growth
-$1.14B
Cap. Flow
-$786M
Cap. Flow %
-52.7%
Top 10 Hldgs %
52.35%
Holding
2,357
New
492
Increased
311
Reduced
506
Closed
984

Sector Composition

Rank Sector Weight
1 Technology 6.31%
2 Consumer Discretionary 3.94%
3 Healthcare 3.91%
4 Communication Services 2.7%
5 Financials 2.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TSG
326
DELISTED
The Stars Group Inc.
TSG
$456K 0.03%
22,307
-25,204
-53% -$567K
WPM icon
327
Wheaton Precious Metals
WPM
$60.6B
$449K 0.03%
16,325
-11,544
-41% -$333K
TWNK
328
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
$440K 0.03%
41,285
-41,351
-50% -$525K
SNV
329
CALL
DELISTED
Synovus
SNV
$439K 0.03%
25,000
ROK icon
330
CALL
Rockwell Automation
ROK
$48.3B
$438K 0.03%
2,900
-8,200
-74% -$1.52M
TRIP icon
331
PUT
TripAdvisor
TRIP
$1.26B
$435K 0.03%
25,000
FMC icon
332
FMC
FMC
$1.31B
$433K 0.03%
5,297
+4,666
+739% +$433K
MS icon
333
Morgan Stanley
MS
$338B
$432K 0.03%
12,698
+9,773
+334% +$460K
SBUX icon
334
Starbucks
SBUX
$119B
$428K 0.03%
6,503
+2,083
+47% +$168K
VLO icon
335
Valero Energy
VLO
$90.7B
$428K 0.03%
9,437
+8,223
+677% +$597K
ARCT icon
336
Arcturus Therapeutics
ARCT
$200M
$426K 0.03%
31,339
+478
+2% +$6.12K
COP icon
337
ConocoPhillips
COP
$148B
$422K 0.03%
13,693
+636
+5% +$32.4K
PCRX icon
338
Pacira BioSciences
PCRX
$974M
$415K 0.03%
12,389
+6,875
+125% +$286K
PRNB
339
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
$415K 0.03%
+6,997
New +$408K
NKE icon
340
PUT
Nike
NKE
$62.5B
$414K 0.03%
+5,000
New +$465K
TAST
341
DELISTED
Carrols Restaurant Group, Inc.
TAST
$410K 0.03%
225,441
-167,900
-43% -$702K
DSSI
342
DELISTED
Diamond S Shipping Inc. Common Shares
DSSI
$398K 0.03%
33,677
-52,455
-61% -$614K
PE
343
DELISTED
PARSLEY ENERGY INC
PE
$395K 0.03%
68,870
-45,228
-40% -$611K
PTON icon
344
Peloton Interactive
PTON
$2.42B
$394K 0.03%
+14,832
New +$412K
EXAS
345
DELISTED
Exact Sciences
EXAS
$391K 0.03%
6,743
+5,240
+349% +$425K
BABA icon
346
PUT
Alibaba
BABA
$317B
$389K 0.03%
2,000
-40,100
-95% -$8.37M
DIS icon
347
CALL
Walt Disney
DIS
$178B
$386K 0.03%
4,000
-58,100
-94% -$7.35M
BIL icon
348
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$46.7B
$381K 0.03%
4,158
-5,842
-58% -$535K
WEN icon
349
Wendy's
WEN
$1.39B
$375K 0.03%
25,219
+19,166
+317% +$377K
XLV icon
350
CALL
State Street Health Care Select Sector SPDR ETF
XLV
$44B
$372K 0.02%
+4,200
New +$408K

Similar funds

Prelude Capital Management's Q1 2020 Portfolio in Review

As of Q1 2020, Prelude Capital Management held 2,357 positions worth $1.49B, down 43% from $2.63B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Prelude Capital Management withdrew a net $786M in Q1 2020, closing 984 positions and reducing 506 holdings. Its most notable exit was Audentes Therapeutics, Inc, an estimated $16.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 6.3% of assets, up from 4.6% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Prelude Capital Management opened a new position in Vanguard Short-Term Corporate Bond ETF worth $10.3M.

  • Prelude Capital Management's largest Q1 2020 buy was Vanguard Short-Term Corporate Bond ETF: 130,000 shares worth $10.3M.
  • Prelude Capital Management added most to IBERIABANK Corp in Q1 2020, an estimated $8.93M increase.
  • Prelude Capital Management's biggest Q1 2020 reduction was Netflix, cutting an estimated $15.8M.
  • Prelude Capital Management fully exited Audentes Therapeutics, Inc in Q1 2020, selling an estimated $16.7M.
  • Prelude Capital Management's ten largest holdings make up 52% of its $1.49B portfolio in Q1 2020.
  • Prelude Capital Management opened 492 new positions and closed 984 in Q1 2020.
  • Prelude Capital Management's portfolio value fell 43% quarter-over-quarter to $1.49B.

Based on Prelude Capital Management's 13F filing for Q1 2020, filed 15 May 2020.